Giger co-founded Quantitative Insights, Inc.,[1] whose product QuantX is the first FDA-cleared, machine-learning driven system to aid in cancer diagnosis.
[2] This makes her the first inventor to successfully develop a system that automatically detects patterns from past cases and outputs a diagnosis on cancer that is equal if not more credible than a doctor's.
Her AI research in breast cancer for risk assessment, diagnosis, prognosis and therapeutic response has yielded various translated components, and she has used these “virtual biopsies” in imaging-genomics association studies.
[6] Giger was elected a member of the National Academy of Engineering in 2010 for contributions to digital signal analysis for improved cancer detection and treatment and for innovations in interdisciplinary training.
[6] In 2020, Dr. Giger was chosen to lead a new center hosted at the University of Chicago established in response to the ongoing COVID-19 pandemic intended to curate a massive database of medical images to help better understand and treat the disease.